Table 19: Other Pain Measurements Used Across Studies.
| Study, Year | N | N for Analysis | Measurement | Result | P |
|---|---|---|---|---|---|
| North et al., (81) 2005 | 50 | 45 | Opioid intake | For increase in opioid use: Treatment: 3/23 (13%) Control: 11/26 (42%) |
.025 |
| Kemler et al., (63) 2004 | 54 | 52 | Global Perceived Effect of treatment score of 6: “much improved” | Treatment: 15/35 (43%) Control: 1/16 (65%) |
.001 |
| Spincemaille et al., (42) 2004 | 105 | 96 | McGill Pain Questionnaire Medication quantification scale |
Mean (SD) Before: 22.4 (9.4) After: 10.8 (8.0) Before: 11.5 (7.9) After: 6.05 (4.8) |
< .05 < .05 |
| Harke et al., (83) 2002 | 25 | 23 | Analgesic consumption | Needed pain medication during SCS Yes: 10/23 (43.5%) No: 13/23 (56.5%) Opioid used: Before: 19/23 (82.6%) After: 1/23 (4.5%) |
.02 .002 |